Cambridge Biotech adopts new trading name:
This article was originally published in Clinica
Executive Summary
Cambridge Biotech is to change its name to Cambridge Diagnostics Ireland, reflecting its location in Galway, Ireland. Cambridge Biotech was acquired by Massachusetts-based Selfcare in November 1994 (see Clinica No 632, p 14). The Galway facility is responsible for the manufacture of, among other assays, Capillus, Recombigen HIV 1/2 and Hepatitis Delta.